Literature DB >> 6424404

Antibiotic susceptibility pattern and capsular types of Haemophilus influenzae recovered from clinical specimens in northern Norway.

K Melby, T Leinslie, N Hagen, L H Vorland.   

Abstract

One hundred and nine strains of Haemophilus influenzae recovered from clinical specimens were examined for antibiotic sensitivity pattern and capsular types. All strains from blood cultures, cerebrospinal fluid and a joint aspirate were type b whereas most of the isolates were acapsular when recovered from other specimens viz. wound secretions (67%), maxillary sinus (75%), lower resp tract (86%), nasal cavity (90%). Out of the 109 strains 88 (81%) were non-typable, and 3.6% were beta-lactamase-producing, two of which were type e, one was type b and one was acapsular. Three beta-lactamase-producing strains were isolated from specimens from the respiratory tract and one from blood cultures. Beta-lactamase-producing strains including one chloramphenicol-resistant strain harboured similar plasmids, as judged by agarose gel electrophoresis. The strains showed quite a uniform sensitivity to antibacterial agents with the exception of sulphonamides to which the capsular strains, particularly type b strains, were less susceptible.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6424404     DOI: 10.1111/j.1699-0463.1983.tb00064.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Immunol Scand B        ISSN: 0108-0180


  2 in total

1.  Distribution and resistance patterns of Haemophilus influenzae: a European cooperative study.

Authors:  K Machka; I Braveny; H Dabernat; K Dornbusch; E Van Dyck; F H Kayser; B Van Klingeren; H Mittermayer; E Perea; M Powell
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-02       Impact factor: 3.267

2.  Antimicrobial resistance among clinical isolates of Haemophilus influenzae in northern Italy. Collaborative Study on Pediatric Infectious Diseases.

Authors:  M L Garlaschi; F Rusconi; R Colombo; F Conio; S Sideri; F Varotto; M Arghittu; C Passerini; A Sala
Journal:  Eur J Epidemiol       Date:  1993-01       Impact factor: 8.082

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.